Clinical Trials Directory

Trials / Unknown

UnknownNCT05793216

VestibulOTherapy: Vestibular Impact on Learning

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
VestibulOTherapy · Industry
Sex
All
Age
6 Years – 10 Years
Healthy volunteers
Not accepted

Summary

Research Question: Will daily engagement in activities tailored to the evidence-based vestibular research result in improved attention and learning outcomes for children ages 6-9 years of age after an 8-week classroom-based intervention?

Detailed description

"Vestibulotherapy" is an emerging frame of reference aiming to help neurotypical children with under-performing vestibular systems develop neural pathways supporting communication and learning. Theory based upon systematic review: Given adequate vestibular activation through targeted activities (in an otherwise under-performing vestibular system), myelination and neuroplasticity propagate along learning pathways leading to greater neural connectivity and efficiency for sequencing, ordinance, attention, memory, body schema, spatial cognition, executive function, and interoception. As a result of prescribed vestibular interventions and gained attributes supporting learning, students will experience increased academic growth and success as outlined by the following model.

Conditions

Interventions

TypeNameDescription
BEHAVIORALVestibulOTherapyFor this study, the following activity-orientated interventions will occur within the natural learning environments so that generous opportunities exist for neural plasticity and growth. Each student will be engaged in 20-30 minutes/day of intermittent classroom activities, plus 20-30- minutes of daily stability work embedded into classroom routines including stabilizing self on a Hokki stool or t-stool or standing on a balance board during sedentary work, such as circle time or read-a-loud.

Timeline

Start date
2023-03-07
Primary completion
2023-05-05
Completion
2023-10-25
First posted
2023-03-31
Last updated
2023-03-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05793216. Inclusion in this directory is not an endorsement.